Spero Therapeutics, Inc.
SPRO
DELAYED 1 MONTH
1 insider filing · Latest: May 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 7 1:53 AM | Esther RajaveluChief Executive Officer, Chief Financial Officer and Chief Business Officer | Sale | 25,240 | $2.51 | $63.4K | 986,851(D) | View → |
Stock Options & Derivatives
No transactions found.